News – GMS Australia – We are delighted to announce receipt from the Therapeutic Goods Administration (TGA) of a GMP licence to enable commercial production of PET radiopharmaceuticals from the cyclotron at the Centre for Advanced Imaging (CAI) at The University of Queensland (UQ), adding to GMS Australia’s current PET product offering. Thank you to the GMS Brisbane and GMSA QA teams, who put in the hard work and dedication to bring our newest project online!
Recent News
- GMS New Zealand To Exit NZMI Auckland Scanning Services
- GMS and HR Pharma Sign Distribution Agreement for EcoVue® in Asia-Pacific
- Telix Pharmaceuticals and Global Medical Solutions Complete Strategic Manufacturing Agreement
- GE Healthcare and GMS Taiwan sign exclusive license agreement for Flutemetamol F-18 Injection (Vizamyl™) in Taiwan
- BWXT and GMS Form Joint Venture in Nuclear Medicine Manufacturing and Distribution in the Asia-Pacific Region
Recent Comments